Cargando…

Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study

Herein we have made a comprehensive analysis of inhibitory efficacy of 16 RNA virus drugs against RdRp, Mpro and PLpro proteins of SARS-CoV-2. Analysis of docked conformation revealed that Baloxavir marboxil (BMX) corresponds to the highest binding energy. Analysis of residue confirmed that BMX stro...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandal, Manab, Chowdhury, Swapan Kumar, Khan, Abdul Ashik, Baildya, Nabajyoti, Dutta, Tanmoy, Misra, Debabrata, Ghosh, Narendra Nath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909904/
https://www.ncbi.nlm.nih.gov/pubmed/33678903
http://dx.doi.org/10.1016/j.molstruc.2021.130152
_version_ 1783656022990127104
author Mandal, Manab
Chowdhury, Swapan Kumar
Khan, Abdul Ashik
Baildya, Nabajyoti
Dutta, Tanmoy
Misra, Debabrata
Ghosh, Narendra Nath
author_facet Mandal, Manab
Chowdhury, Swapan Kumar
Khan, Abdul Ashik
Baildya, Nabajyoti
Dutta, Tanmoy
Misra, Debabrata
Ghosh, Narendra Nath
author_sort Mandal, Manab
collection PubMed
description Herein we have made a comprehensive analysis of inhibitory efficacy of 16 RNA virus drugs against RdRp, Mpro and PLpro proteins of SARS-CoV-2. Analysis of docked conformation revealed that Baloxavir marboxil (BMX) corresponds to the highest binding energy. Analysis of residue confirmed that BMX strongly interact with these three proteins involving H-bonding, ionic as well as hydrophobic interactions. Molecular dynamics simulation and analysis of parameters like RMSD, RMSF, binding energy confirmed noticeable conformational alternation with these proteins with makeable effect on RdRp. The potentially inhibitory action of BMX against these three proteins suggests the inhibition of overall transcription process of SARS-CoV-2. These observation along with the recently observed inhibitory action of BMX on influenza with clinically proven no side effects emphasizes to uncover the role of BMX by in-vitro and in-vivo analysis.
format Online
Article
Text
id pubmed-7909904
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-79099042021-03-01 Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study Mandal, Manab Chowdhury, Swapan Kumar Khan, Abdul Ashik Baildya, Nabajyoti Dutta, Tanmoy Misra, Debabrata Ghosh, Narendra Nath J Mol Struct Article Herein we have made a comprehensive analysis of inhibitory efficacy of 16 RNA virus drugs against RdRp, Mpro and PLpro proteins of SARS-CoV-2. Analysis of docked conformation revealed that Baloxavir marboxil (BMX) corresponds to the highest binding energy. Analysis of residue confirmed that BMX strongly interact with these three proteins involving H-bonding, ionic as well as hydrophobic interactions. Molecular dynamics simulation and analysis of parameters like RMSD, RMSF, binding energy confirmed noticeable conformational alternation with these proteins with makeable effect on RdRp. The potentially inhibitory action of BMX against these three proteins suggests the inhibition of overall transcription process of SARS-CoV-2. These observation along with the recently observed inhibitory action of BMX on influenza with clinically proven no side effects emphasizes to uncover the role of BMX by in-vitro and in-vivo analysis. Elsevier B.V. 2021-06-15 2021-02-26 /pmc/articles/PMC7909904/ /pubmed/33678903 http://dx.doi.org/10.1016/j.molstruc.2021.130152 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Mandal, Manab
Chowdhury, Swapan Kumar
Khan, Abdul Ashik
Baildya, Nabajyoti
Dutta, Tanmoy
Misra, Debabrata
Ghosh, Narendra Nath
Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study
title Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study
title_full Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study
title_fullStr Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study
title_full_unstemmed Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study
title_short Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study
title_sort inhibitory efficacy of rna virus drugs against sars-cov-2 proteins: an extensive study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909904/
https://www.ncbi.nlm.nih.gov/pubmed/33678903
http://dx.doi.org/10.1016/j.molstruc.2021.130152
work_keys_str_mv AT mandalmanab inhibitoryefficacyofrnavirusdrugsagainstsarscov2proteinsanextensivestudy
AT chowdhuryswapankumar inhibitoryefficacyofrnavirusdrugsagainstsarscov2proteinsanextensivestudy
AT khanabdulashik inhibitoryefficacyofrnavirusdrugsagainstsarscov2proteinsanextensivestudy
AT baildyanabajyoti inhibitoryefficacyofrnavirusdrugsagainstsarscov2proteinsanextensivestudy
AT duttatanmoy inhibitoryefficacyofrnavirusdrugsagainstsarscov2proteinsanextensivestudy
AT misradebabrata inhibitoryefficacyofrnavirusdrugsagainstsarscov2proteinsanextensivestudy
AT ghoshnarendranath inhibitoryefficacyofrnavirusdrugsagainstsarscov2proteinsanextensivestudy